I have been following Noom since April 12, 2021 because I needed a program to help me be accountable and find a positive focus after my diagnosis of NAFLD/NASH/Cirrhosis. So I thought this was interesting that they are looking at liver disease research.
Below I have copied and pasted the information and a link to the page if you’re interested.
https://web.noom.com/research/participate-in-research/
REMOTE / ONLINE Do you have nonalcoholic fatty liver disease? You may be eligible to participate in a weight loss research study conducted by Penn State (utilizing Noom). The goal of this research study is to evaluate the effectiveness of a weight loss app for patients with a severe form of fatty liver disease called nonalcoholic steatohepatitis, or NASH. Participation requirements: Adults at least 18 years old with nonalcoholic steatohepatitis (NASH), own a smartphone, no recent participation in weight loss programs or use of weight loss supplements, no other liver diseases. Participants will receive access to use a weight loss app on their smartphone for 16 weeks and a digital scale will be provided. For more information, please contact Gloriany Rivas at stinelaboratory@pennstatehealth.psu.edu (717-531-0003, ext. 320223). The Study Director is Jonathan G. Stine, MD, Department of Medicine, Penn State Health.
Comments